Sonidegib (Odomzo) Approved for Basal Cell Carcinoma in EUSonidegib (Odomzo) Approved for Basal Cell Carcinoma in EU

The new drug is approved for patients with locally advanced basal cell carcinoma who are not amenable to curative therapy or radiation. News Alerts
Source: Medscape Hematology-Oncology Headlines - Category: Cancer & Oncology Tags: Hematology-Oncology News Alert Source Type: news